Elevated Prevalence Of Heart Diseases As A Catalyst For Biomarkers Market Expansion : A Key Factor Shaping the Future of the Biomarkers Market in 2025

What combination of drivers is leading to accelerated growth in the biomarkers market?
The escalating trend in cardiac conditions can be linked to the growth of the biomarkers market in the projected timeframe. The utilisation of biomarkers in cardiac patients has witnessed significant acceleration in the recent past. Presently, natriuretic peptides are the most commonly utilized biomarkers for diagnosing heart failure cases. High sensitivity C-reactive protein and other circulating biomarkers are also routinely used in the diagnosis of cardiac failure. Cardiac disease is a major cause of mortality in diverse racial and ethnic groups in the United States. Hence, the surge in cardiac diseases will inevitably catalyze the demand for biomarkers. For instance, in August 2022, a study by the American College of Cardiology, a US-based charitable medical association, predicted that all four cardiovascular risk factors in the United States are likely to witness an upward trajectory between 2025 and 2060. The highest projected surge is expected in diabetes with a 39.3% increase to 55 million individuals, followed by dyslipidemia (27.6% to 126 million), hypertension (25.1% to 162 million), and obesity (18.3% to 126 million). They also highlighted expected surges in the rate of stroke (33.8% to 15 million) and heart failure (33.4% to 13 million), followed by ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million). The rising incidence of cardiac diseases and deaths will drive the biomarkers market's growth.

Get Your Biomarkers Market Report Here:
https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

What is the projected compound annual growth rate (CAGR) of the biomarkers market from 2025 to 2034, and what factors influence it?
Over the past few years, the size of the biomarkers market has expanded rapidly. It is projected to grow from a sizable $68.77 billion in 2024 to an even larger $78.14 billion in 2025, at a compounded annual growth rate (CAGR) of 13.6%. This significant increase in the historical timeline can be traced back to the improvements in genomics and proteomics technologies, a rising occurrence of chronic illnesses, a growing focus on personalized medicine, an upsurge in the hunt for companion diagnostics, and a widening of applications within the realm of drug development.

Over the upcoming years, the biomarkers market is forecasted to witness tremendous expansion. The market is predicted to touch a mark of $135.14 billion in 2029, with a compound annual growth rate (CAGR) of 14.7%. This growth during the prediction period is primarily influenced by the increasing emphasis on early detection and prevention of diseases, the widespread use of biomarkers in oncology and immunotherapy, escalated investments in precision medicine initiatives, the rising prominence of liquid biopsy as a non-invasive method for biomarker detection, and the growing inclination towards using biomarkers in drug discovery and development. Key trends pertaining to the prediction period encompass the development of multi-biomarker panels, emergence of exosome-based biomarkers, widespread adoption of point-of-care biomarker testing, incorporation of real-world data in biomarker research, and exploration of microbiome-based biomarkers.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6485&type=smp

How are the latest trends influencing the growth of the biomarkers market?
Key businesses within the biomarker sector are directing their efforts towards the advancement of original and inventive solutions, such as a groundbreaking biological marker. This is done through synergistic research, technology amalgamation, and substantial clinical validation. A cutting-edge biological marker serves as a recently identified sign of biological processes, aiding in the detection and tracking of diseases. Such markers could be molecular, gene-based, or a characteristic of a cell, with significant potential for bespoke medicine. In September 2024, for example, a first-of-its-kind biomarker was unveiled by Genialis, an American firm specializing in computational precision medicine. This pioneering biomarker provides improved predictions of patient responses to KRAS inhibitors, allowing for personalized treatment plans and better patient outcomes. With its wide-ranging application in diverse cancer types, it enhances efficient drug development and refines the selection process for targeted therapies.

What are the major segments of the biomarkers market and their role in driving growth?
The biomarkers market covered in this report is segmented -

1) By Technology: Safety Biomarkers, Efficacy Biomarkers, Validation Biomarkers
2) By Disease: Neurological Diseases, Cancer, Immunological Diseases, Cardiovascular Diseases, Other Diseases
3) By Type: Biomarker Of Exposure, Biomarker Of Diseases
4) By Audiences: Pharmaceutical Companies, Government And Private Research Institutes, Academic Institutes, Medical Device Manufacturing Companies

Subsegments:
1) By Safety Biomarkers: Toxicity Biomarkers, Pharmacokinetic Biomarkers, Adverse Effect Biomarkers
2) By Efficacy Biomarkers: Pharmacodynamic Biomarkers, Disease Progression Biomarkers, Treatment Response Biomarkers
3) By Validation Biomarkers: Analytical Validation Biomarkers, Clinical Validation Biomarkers, Qualification Biomarkers

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6485

Which regions are key players in the growth of the biomarkers market?
North America was the largest region in the biomarkers market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the key firms paving the way for growth in the biomarkers market?
Major companies operating in the biomarkers market include Enzo Biochem Inc, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N. V., Adaptive Biotechnologies Corp., Agilent Technologies Inc., Biocrates Life Sciences AG, BioFire Diagnostics LLC, BioReference Laboratories Inc., Bio-Techne Corporation, Cepheid Inc., Eurofins Scientific SE, Exact Sciences Corporation, Foundation Medicine Inc., Genomic Health Inc., GenScript Biotech Corporation, Guardant Health Inc., Illumina Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Luminex Corporation, Metabolon Inc., Myriad Genetics Inc., Natera Inc., Pacific Biosciences of California Inc., Quest Diagnostics Incorporated, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Veracyte Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=6485&type=smp

What Is Covered In The Biomarkers Global Market Report?

•Market Size Forecast: Examine the biomarkers market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the biomarkers market for a structured understanding.
•Key Players Overview: Analyze major players in the biomarkers market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the biomarkers market.
•Segment Contributions: Evaluate how different segments drive overall growth in the biomarkers market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the biomarkers market.
•Industry Challenges: Identify potential risks and obstacles affecting the biomarkers market.
•Competitive Landscape: Review strategic developments in the biomarkers market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.